Literature DB >> 26527309

Unusual case of drug-induced cholestasis due to glucosamine and chondroitin sulfate.

Stephen Ip1, Rachel Jeong1, David F Schaeffer1, Eric M Yoshida1.   

Abstract

Glucosamine (GS) and chondroitin sulfate (CS) are common over-the-counter (OTC) supplements used in the treatment of osteoarthritis. These medications are seemingly safe, but there are increasing reports of hepatotoxicity with these supplements. We reported a unique case of drug-induced cholestasis caused by GS and CS in a combination tablet. The etiology of the jaundice was overlooked despite extensive investigations over a three-month period. Unlike drug-induced hepatocellular injury, drug-induced cholestatic jaundice with GS and CS has only been reported twice before. This case emphasizes the importance of a complete medication history, especially OTC supplements, in the assessment of cholestasis.

Entities:  

Keywords:  Cholestasis; Chondroitin; Glucosamine; Hepatotoxicity; Jaundice

Year:  2015        PMID: 26527309      PMCID: PMC4621470          DOI: 10.4254/wjh.v7.i24.2559

Source DB:  PubMed          Journal:  World J Hepatol


  10 in total

1.  Is glucosamine safe in patients with seafood allergy?

Authors:  Heather C Gray; Patricia S Hutcheson; Raymond G Slavin
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

2.  [Acute cholestatic hepatitis due to glucosamine forte].

Authors:  Roch Anicet Ossendza; Philippe Grandval; Farid Chinoune; Fanny Rocher; Françoise Chapel; David Bernardini
Journal:  Gastroenterol Clin Biol       Date:  2007-04

3.  Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.

Authors:  Marlene Fransen; Maria Agaliotis; Lillias Nairn; Milana Votrubec; Lisa Bridgett; Steve Su; Stephen Jan; Lyn March; John Edmonds; Robyn Norton; Mark Woodward; Richard Day
Journal:  Ann Rheum Dis       Date:  2014-01-06       Impact factor: 19.103

4.  Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies.

Authors:  Aileen Smith; John Dillon
Journal:  BMJ Case Rep       Date:  2009-09-02

5.  Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT.

Authors:  Allen D Sawitzke; Helen Shi; Martha F Finco; Dorothy D Dunlop; Crystal L Harris; Nora G Singer; John D Bradley; David Silver; Christopher G Jackson; Nancy E Lane; Chester V Oddis; Fred Wolfe; Jeffrey Lisse; Daniel E Furst; Clifton O Bingham; Domenic J Reda; Roland W Moskowitz; H James Williams; Daniel O Clegg
Journal:  Ann Rheum Dis       Date:  2010-06-04       Impact factor: 19.103

Review 6.  Hepatotoxicity associated with chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature.

Authors:  Sunny A Linnebur; Olivia C Rapacchietta; Maria Vejar
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

Review 7.  Glucosamine therapy for treating osteoarthritis.

Authors:  T E Towheed; L Maxwell; T P Anastassiades; B Shea; J Houpt; V Robinson; M C Hochberg; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 8.  Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis.

Authors:  Simon Wandel; Peter Jüni; Britta Tendal; Eveline Nüesch; Peter M Villiger; Nicky J Welton; Stephan Reichenbach; Sven Trelle
Journal:  BMJ       Date:  2010-09-16

9.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

10.  Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease.

Authors:  Cristian Cerda; Miguel Bruguera; Albert Parés
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.